659 related articles for article (PubMed ID: 21040645)
1. Relapse prevention in UK Stop Smoking Services: current practice, systematic reviews of effectiveness and cost-effectiveness analysis.
Coleman T; Agboola S; Leonardi-Bee J; Taylor M; McEwen A; McNeill A
Health Technol Assess; 2010 Oct; 14(49):1-152, iii-iv. PubMed ID: 21040645
[TBL] [Abstract][Full Text] [Related]
2. A systematic review of the effectiveness of smoking relapse prevention interventions for abstinent smokers.
Agboola S; McNeill A; Coleman T; Leonardi Bee J
Addiction; 2010 Aug; 105(8):1362-80. PubMed ID: 20653619
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of interventions to reduce relapse to smoking following smoking cessation.
Taylor M; Leonardi-Bee J; Agboola S; McNeill A; Coleman T
Addiction; 2011 Oct; 106(10):1819-26. PubMed ID: 21561499
[TBL] [Abstract][Full Text] [Related]
4. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2012 Apr; (4):CD006103. PubMed ID: 22513936
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological interventions for smoking cessation: an overview and network meta-analysis.
Cahill K; Stevens S; Perera R; Lancaster T
Cochrane Database Syst Rev; 2013 May; 2013(5):CD009329. PubMed ID: 23728690
[TBL] [Abstract][Full Text] [Related]
6. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2011 Feb; (2):CD006103. PubMed ID: 21328282
[TBL] [Abstract][Full Text] [Related]
7. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2010 Dec; (12):CD006103. PubMed ID: 21154363
[TBL] [Abstract][Full Text] [Related]
8. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Lindson-Hawley N; Thomas KH; Fanshawe TR; Lancaster T
Cochrane Database Syst Rev; 2016 May; 2016(5):CD006103. PubMed ID: 27158893
[TBL] [Abstract][Full Text] [Related]
9. What is the clinical effectiveness and cost-effectiveness of cytisine compared with varenicline for smoking cessation? A systematic review and economic evaluation.
Leaviss J; Sullivan W; Ren S; Everson-Hock E; Stevenson M; Stevens JW; Strong M; Cantrell A
Health Technol Assess; 2014 May; 18(33):1-120. PubMed ID: 24831822
[TBL] [Abstract][Full Text] [Related]
10. Relapse prevention interventions for smoking cessation.
Livingstone-Banks J; Norris E; Hartmann-Boyce J; West R; Jarvis M; Hajek P
Cochrane Database Syst Rev; 2019 Feb; 2(2):CD003999. PubMed ID: 30758045
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and cost-effectiveness of computer and other electronic aids for smoking cessation: a systematic review and network meta-analysis.
Chen YF; Madan J; Welton N; Yahaya I; Aveyard P; Bauld L; Wang D; Fry-Smith A; Munafò MR
Health Technol Assess; 2012; 16(38):1-205, iii-v. PubMed ID: 23046909
[TBL] [Abstract][Full Text] [Related]
12. Smoking cessation medicines and e-cigarettes: a systematic review, network meta-analysis and cost-effectiveness analysis.
Thomas KH; Dalili MN; López-López JA; Keeney E; Phillippo D; Munafò MR; Stevenson M; Caldwell DM; Welton NJ
Health Technol Assess; 2021 Oct; 25(59):1-224. PubMed ID: 34668482
[TBL] [Abstract][Full Text] [Related]
13. Nicotine receptor partial agonists for smoking cessation.
Cahill K; Stead LF; Lancaster T
Cochrane Database Syst Rev; 2008 Jul; (3):CD006103. PubMed ID: 18646137
[TBL] [Abstract][Full Text] [Related]
14. Relapse prevention interventions for smoking cessation.
Hajek P; Stead LF; West R; Jarvis M; Hartmann-Boyce J; Lancaster T
Cochrane Database Syst Rev; 2013 Aug; (8):CD003999. PubMed ID: 23963584
[TBL] [Abstract][Full Text] [Related]
15. Relapse prevention interventions for smoking cessation.
Livingstone-Banks J; Norris E; Hartmann-Boyce J; West R; Jarvis M; Chubb E; Hajek P
Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684681
[TBL] [Abstract][Full Text] [Related]
16. 'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis.
Wang D; Connock M; Barton P; Fry-Smith A; Aveyard P; Moore D
Health Technol Assess; 2008 Feb; 12(2):iii-iv, ix-xi, 1-135. PubMed ID: 18093448
[TBL] [Abstract][Full Text] [Related]
17. Interventions to increase adherence to medications for tobacco dependence.
Hollands GJ; Naughton F; Farley A; Lindson N; Aveyard P
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009164. PubMed ID: 31425618
[TBL] [Abstract][Full Text] [Related]
18. Interventions for preventing weight gain after smoking cessation.
Parsons AC; Shraim M; Inglis J; Aveyard P; Hajek P
Cochrane Database Syst Rev; 2009 Jan; (1):CD006219. PubMed ID: 19160269
[TBL] [Abstract][Full Text] [Related]
19. Cost effectiveness of varenicline in Belgium, compared with bupropion, nicotine replacement therapy, brief counselling and unaided smoking cessation: a BENESCO Markov cost-effectiveness analysis.
Annemans L; Nackaerts K; Bartsch P; Prignot J; Marbaix S
Clin Drug Investig; 2009; 29(10):655-65. PubMed ID: 19715382
[TBL] [Abstract][Full Text] [Related]
20. Interventions to increase adherence to medications for tobacco dependence.
Hollands GJ; McDermott MS; Lindson-Hawley N; Vogt F; Farley A; Aveyard P
Cochrane Database Syst Rev; 2015 Feb; (2):CD009164. PubMed ID: 25914910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
